All updated as on -
By 2030, the market for sevoflurane is anticipated to reach USD 1252.2 billion, growing at a CAGR of 4.5% from 2021 to 2030. Throughout the forecast period, it is projected that inorganic activities like partnerships, agreements, acquisitions, and others will rank among the main growth drivers of the worldwide sevoflurane market. Rising research & development activities, rising product launches and approvals, and rising product launches are other growth factors.
Sevoflurane is one of the general anaesthetics that are included in the group of drugs referred to as anaesthetics. General anaesthesia is provided during and after surgical procedures via the use of sevoflurane (which causes unconsciousness). For sevoflurane, inhalation is the preferred delivery mechanism. Although sevoflurane can be delivered on its own, it is usually combined with a number of additional anaesthetics. In some persons, this may help produce anaesthetics with greater potency. Sevoflurane makes it easier to keep the patient's blood pressure and heart rate stable during the surgery. Sevoflurane can also be used to help with postoperative pain management. Throughout the forecast period, it is projected that inorganic operations like acquisitions, partnerships, collaborations, and others will rank among the main growth drivers of the worldwide sevoflurane market. Rising research & development activities, rising product launches and approvals, and rising product launches are other growth factors. For instance, Tenet Healthcare Corporation, a provider of diverse healthcare services, and United Surgical Partners International (USPI) announced in November 2021 that they had reached a legally binding agreement with the owners of SurgCenter Development (SCD) to acquire SCD. This agreement would enable Tenet Healthcare Corporation to acquire SurgCenter Development. Tenet/USPI will purchase SCD's ownership interests in 92 ambulatory surgery centres (ASCs) and related ambulatory support services in accordance with the conditions of the agreement. To meet the surgical needs of the Indian population, 3646 surgeries were performed, according to the World Journal of Surgery, published in 2021. In comparison, 5000 procedures are performed for every 100,000 people worldwide. Caesarean sections, cataract operations, fracture repairs, and hernia repairs were the most frequently performed surgical procedures. In April 2021, a Phase 4 trial comparing sevoflurane and propofol sedation in end-stage renal failure (ESRF) patients undergoing transposition of brachiocephalic fistula repair was launched at the University of Malaya, a public research university in Kuala Lumpur, Malaysia. The goal of the study was to identify the sedation technique that improved patients' quality of life the most.
The sevoflurane market is divided into induction and maintenance based on the kind of application. With the largest market share of 55% and the highest market value of 203.61 billion in 2021, the maintenance segment led the market. The Maintenance segment will generate the largest portion of the market's revenue since it uses ethylene oxide and irradiation to sterilise sevoflurane as procedures. The sector is also developing as a result of increased interest in sevoflurane preservation.
Report Coverage
Global Sevoflurane research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Sevoflurane report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Sevoflurane competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Sevoflurane market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Sevoflurane market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Sevoflurane market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Abbott Laboratories, Baxter, Manus Aktteva Biopharma LLP, Piramal Pharma Solutions, Lunan Pharmaceutical Group, Wellona Pharma, Troikaa Pharmaceuticals Limited, Maruishi Pharmaceutical Co., Ltd., Abbvie, Rewine Pharmaceutical
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Sevoflurane market based on the below-mentioned segments:
Global Sevoflurane Market, By Distribution Channel
Global Sevoflurane market, By Application
Global Sevoflurane market, Regional Analysis
Sevoflurane is one of the general anaesthetics that are included in the group of drugs referred to as anaesthetics. General anaesthesia is provided during and after surgical procedures via the use of sevoflurane (which causes unconsciousness). For sevoflurane, inhalation is the preferred delivery mechanism. Although sevoflurane can be delivered on its own, it is usually combined with a number of additional anaesthetics. In some persons, this may help produce anaesthetics with greater potency. Sevoflurane makes it easier to keep the patient's blood pressure and heart rate stable during the surgery. Sevoflurane can also be used to help with postoperative pain management. Throughout the forecast period, it is projected that inorganic operations like acquisitions, partnerships, collaborations, and others will rank among the main growth drivers of the worldwide sevoflurane market. Rising research & development activities, rising product launches and approvals, and rising product launches are other growth factors. For instance, Tenet Healthcare Corporation, a provider of diverse healthcare services, and United Surgical Partners International (USPI) announced in November 2021 that they had reached a legally binding agreement with the owners of SurgCenter Development (SCD) to acquire SCD. This agreement would enable Tenet Healthcare Corporation to acquire SurgCenter Development. Tenet/USPI will purchase SCD's ownership interests in 92 ambulatory surgery centres (ASCs) and related ambulatory support services in accordance with the conditions of the agreement. To meet the surgical needs of the Indian population, 3646 surgeries were performed, according to the World Journal of Surgery, published in 2021. In comparison, 5000 procedures are performed for every 100,000 people worldwide. Caesarean sections, cataract operations, fracture repairs, and hernia repairs were the most frequently performed surgical procedures. In April 2021, a Phase 4 trial comparing sevoflurane and propofol sedation in end-stage renal failure (ESRF) patients undergoing transposition of brachiocephalic fistula repair was launched at the University of Malaya, a public research university in Kuala Lumpur, Malaysia. The goal of the study was to identify the sedation technique that improved patients' quality of life the most.
The sevoflurane market is divided into induction and maintenance based on the kind of application. With the largest market share of 55% and the highest market value of 203.61 billion in 2021, the maintenance segment led the market. The Maintenance segment will generate the largest portion of the market's revenue since it uses ethylene oxide and irradiation to sterilise sevoflurane as procedures. The sector is also developing as a result of increased interest in sevoflurane preservation.
Report Coverage
Global Sevoflurane research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Sevoflurane report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Sevoflurane competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Sevoflurane market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2020 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2019 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Abbott Laboratories, Baxter, Manus Aktteva Biopharma LLP, Piramal Pharma Solutions, Lunan Pharmaceutical Group, Wellona Pharma, Troikaa Pharmaceuticals Limited, Maruishi Pharmaceutical Co., Ltd., Abbvie, Rewine Pharmaceutical |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Sevoflurane Market from 2021 to 2030.
- Market Forecast for Sevoflurane Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Sevoflurane competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Sevoflurane
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Sevoflurane market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Sevoflurane market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Abbott Laboratories, Baxter, Manus Aktteva Biopharma LLP, Piramal Pharma Solutions, Lunan Pharmaceutical Group, Wellona Pharma, Troikaa Pharmaceuticals Limited, Maruishi Pharmaceutical Co., Ltd., Abbvie, Rewine Pharmaceutical
Primary Target Market
- Market Players of Sevoflurane
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Sevoflurane market based on the below-mentioned segments:
Global Sevoflurane Market, By Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Global Sevoflurane market, By Application
- Induction
- Maintenance
Global Sevoflurane market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive sevoflurane market market research and competitor analysis for your business to help you develop more profound insights into the sevoflurane market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the sevoflurane market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.